Senior Director, Regulatory Affairs REMS Program

Responsibilities

Serve as regulatory lead and FDA point of contact for all REMS-related interactions, including original REMS submissions, assessments, modifications, and revisions.
Lead development of REMS strategies that align with benefit–risk profile, labeling, post marketing commitments, and lifecycle plans.
Drive cross-functional alignment and decision-making.
Prepare and lead REMS discussions for FDA meetings (Type A/B/C, Advisory Committees, inspections)
Manage all aspects of preparation and timely submission of REMS filings, REMS assessments, and responses to queries
Oversee implementation and evaluation of REMS in alignment with the broader program strategy
Monitor evolving FDA REMS guidance and proactively assess regulatory impact
Provide regulatory guidance to Commercial, Market Access, and Patient Services to ensure compliant execution.
Identify gaps that may pose regulatory risks and identify related solutions and mitigation plans
Develop and maintain internal regulatory processes, templates, and best practices
REMS Design & Governance
Own global oversight of REMS design, including Elements to Assure Safe Use (ETASU), communication plans, implementation systems, and assessment methodologies
Act as a key member of the REMS governance committee, leading compliance and assessment/reporting functions and partnering with operations to ensure end-to-end program oversight and regulatory compliance.
Ensure REMS requirements are clearly translated into operational execution plans.

Qualifications

• 10+ years of relevant experience in the pharmaceutical/biotech industry, with strong expertise in REMS operations, strategy and compliance
• Bachelor’s degree is required, preferably in a scientific discipline; advanced degree (MD, PharmD, or PhD) is a plus
• Excellent working knowledge of regulatory requirements and environment applicable to REMS, including an understanding of GXP
• Direct experience leading or negotiating REMS with FDA strongly preferred
• Able to work effectively across teams, functions and with outside partners
• Excellent oral and written communication skills
• Excellent organizational and time management skills, attention to detail, and ability to independently drive deliverables to completion
• Able to work effectively in a fast-paced environment while managing multiple priorities

Pay

In the U.S., the hiring pay range for fully qualified candidates is $263,880 - $307,860 per year. The base pay actually offered will take into account internal equity and also may vary depending on the candidate's geographic region, job-related knowledge, skills, and experience among other factors.

Contact Us

Please review our General Data Protection Regulation (GDPR) policy PRIOR to applying. Our passion is anchored in robust scientific thinking, grounded in integrity and critical thinking. We keep the patient front and center in all we do – all actions and decisions are in service of the patient and their caregivers. We champion integrity, ethics, doing the right thing, and being our best selves. Fraud Warning: How to Identify Impersonated Cytokinetics Job Postings and Offers Recently, there have been fraudulent employment offers being sent to candidates on behalf of Cytokinetics. Please be advised that all legitimate offers from Cytokinetics will come directly from our official email domain (Cytokinetics.com) and will only be made after completing a formal interview process. Here Are Some Ways To Check For Authenticity
We do not conduct job interviews through non-standard text messaging applications
We will never request personal information such as banking details until after an official offer has been accepted and verified
We will never request that you purchase equipment or other items when interviewing or hiring
If you are unsure about the authenticity of an offer, or if you receive any suspicious communication, please contact us directly at talentacquisition@cytokinetics.com

About Cytokinetics

Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction.